Back
EAPC Premium Access

Evaluation of the knowledge of patients about the management of their treatment with vitamin k antagonist drugs: prospective study about 100 patients.

Session: Poster Session 1 - Cardiovascular Pharmacotherapy
Topic: Cardiovascular Pharmacotherapy
Speaker: Doctor M. Mouadili (Marrakech, MA)
Event: EuroPrevent 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Maryam Mouadili

Marrakech University Hospital, Marrakech (Morocco)
0 follower

13 more presentations in this session

Prognostic impact of proton pump inhibitors in patients after elective percutaneous coronary intervention with implantation of second-generation drug eluting stents

Speaker: Doctor O. Shahmatova (Moscow, RU)

Access
Like
Thumbnail

A novel direct method to evaluate adherence to atorvastatin therapy in coronary prevention - Cut-off values generated in a clinical non-adherence study

Speaker: Doctor O. Kristiansen (Drammen, NO)

Access
Abstract
Like
Thumbnail

The relationship of drug treatment safety parameters and adherence to pharmacotherapy in patients with cardiovascular diseases (according to the data of the outpatient registry)

Speaker: Doctor Y. Lukina (Moscow, RU)

Access
Abstract
Like
Thumbnail

Focus-group as a qualitative method for study of compliance in cardiovascular disease patients and their doctors

Speaker: Doctor O. Semenova (Saratov, RU)

Access
Abstract
Like
Thumbnail

Adherence to long-term treatment and some traits of patients and their doctors: a prospective study of treatment compliance in patients with cardiovascular diseases

Speaker: Doctor Y. Bulaeva (Saratov, RU)

Access
Like
Thumbnail

Access the full session

Poster Session 1 - Cardiovascular Pharmacotherapy

Speakers: Doctor M. Mouadili, Doctor O. Shahmatova, Doctor O. Kristiansen, Doctor Y. Lukina, Doctor O. Semenova...
Access
Like
Thumbnail

About the event

Image

EuroPrevent 2019

11 April - 13 April 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources